1. Home
  2. VS vs RNAZ Comparison

VS vs RNAZ Comparison

Compare VS & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • RNAZ
  • Stock Information
  • Founded
  • VS 2013
  • RNAZ 2016
  • Country
  • VS United States
  • RNAZ United States
  • Employees
  • VS N/A
  • RNAZ N/A
  • Industry
  • VS EDP Services
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • RNAZ Health Care
  • Exchange
  • VS Nasdaq
  • RNAZ Nasdaq
  • Market Cap
  • VS 7.0M
  • RNAZ 7.8M
  • IPO Year
  • VS N/A
  • RNAZ 2021
  • Fundamental
  • Price
  • VS $1.50
  • RNAZ $8.76
  • Analyst Decision
  • VS Hold
  • RNAZ Strong Buy
  • Analyst Count
  • VS 1
  • RNAZ 1
  • Target Price
  • VS $2.00
  • RNAZ $280.00
  • AVG Volume (30 Days)
  • VS 12.5K
  • RNAZ 15.3K
  • Earning Date
  • VS 11-14-2025
  • RNAZ 11-14-2025
  • Dividend Yield
  • VS N/A
  • RNAZ N/A
  • EPS Growth
  • VS N/A
  • RNAZ N/A
  • EPS
  • VS N/A
  • RNAZ N/A
  • Revenue
  • VS $2,179,348.00
  • RNAZ N/A
  • Revenue This Year
  • VS $3,459.21
  • RNAZ N/A
  • Revenue Next Year
  • VS N/A
  • RNAZ N/A
  • P/E Ratio
  • VS N/A
  • RNAZ N/A
  • Revenue Growth
  • VS 2281.70
  • RNAZ N/A
  • 52 Week Low
  • VS $1.39
  • RNAZ $6.15
  • 52 Week High
  • VS $3.79
  • RNAZ $468.44
  • Technical
  • Relative Strength Index (RSI)
  • VS 30.46
  • RNAZ 39.48
  • Support Level
  • VS $1.41
  • RNAZ $8.48
  • Resistance Level
  • VS $1.56
  • RNAZ $9.42
  • Average True Range (ATR)
  • VS 0.09
  • RNAZ 0.57
  • MACD
  • VS -0.01
  • RNAZ -0.01
  • Stochastic Oscillator
  • VS 16.46
  • RNAZ 38.55

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: